GSK denies reverse payment

Published: 2011-10-25 06:58:00

Updated: 2011-10-25 06:58:00

GlaxoSmithKline has been fined for colluding with Dong-A Pharmaceutical to hinder the generic sale of its anti-emetic Zofran for the past 12 years, antitrust authorities said Sunday.

It is the first time that a multinational drug company has been found to offer financial benefits in return fo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK